Disc Medicine, Inc. (IRON)
NASDAQ: IRON · Real-Time Price · USD
66.86
-2.84 (-4.07%)
At close: May 15, 2026, 4:00 PM EDT
66.50
-0.36 (-0.54%)
After-hours: May 15, 2026, 5:44 PM EDT
Disc Medicine Market Cap
Disc Medicine has a market cap or net worth of $2.55 billion as of May 15, 2026. Its market cap has increased by 71.73% in one year.
Market Cap
2.55B
Enterprise Value
1.85B
1-Year Change
71.73%
Ranking
Category
Stock Price
$66.86
Market Cap Chart
Since May 17, 2021, Disc Medicine's market cap has increased from $475.61M to $2.55B, an increase of 436.99%. That is a compound annual growth rate of 39.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 2.58B | -7.54% |
| Dec 31, 2025 | 2.79B | 47.19% |
| Dec 31, 2024 | 1.90B | 39.45% |
| Dec 29, 2023 | 1.36B | 5,052.55% |
| Dec 30, 2022 | 26.41M | -84.19% |
| Dec 31, 2021 | 167.03M | -64.88% |
| May 17, 2021 | 475.61M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tarsus Pharmaceuticals | 2.80B |
| Kailera Therapeutics | 2.79B |
| Soleno Therapeutics | 2.76B |
| Arcutis Biotherapeutics | 2.75B |
| Structure Therapeutics | 2.70B |
| Enliven Therapeutics | 2.59B |
| Celldex Therapeutics | 2.56B |
| Ultragenyx Pharmaceutical | 2.55B |